{"product_id":"tirz3patid4-40mg","title":"Tirz3patid4 40Mg","description":"\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eTIRZEPATIDE — Advanced Dual GIP \u0026amp; GLP-1 Receptor Agonist\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eMetabolic Research | Glucose Regulation | Weight Management | Incretin-Based Therapy\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eProduct Overview\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eTirzepatide is a synthetic peptide and dual GIP\/GLP-1 receptor agonist developed by Eli Lilly and marketed under the brand name Mounjaro®.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIt is an approved once-weekly injectable prescription medication in Portugal and the European Union for the treatment of type 2 diabetes and weight management in eligible patients with obesity or overweight accompanied by weight-related health conditions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTirzepatide simultaneously activates two important metabolic hormone receptors: \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eglucose-dependent insulinotropic polypeptide (GIP)\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e and \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eglucagon-like peptide-1 (GLP-1)\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThrough this dual mechanism, tirzepatide influences insulin secretion, appetite regulation, satiety, and energy intake, making it an important subject of metabolic and pharmaceutical research.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eMechanism of Action\u003c\/span\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGIP Receptor Activation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Enhances glucose-dependent insulin secretion and contributes to metabolic regulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGLP-1 Receptor Activation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Promotes satiety, reduces appetite, and influences gastric emptying.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGlucose Homeostasis:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Supports blood glucose regulation through incretin-related mechanisms.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBody Weight Regulation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Reduces food intake through effects on appetite and satiety, contributing to weight reduction in clinical studies.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eMetabolic Research:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Provides opportunities to investigate the interaction between incretin signaling, insulin function, and energy balance.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eClinical Research \u0026amp; Scientific Evidence\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eClinical trials have demonstrated significant reductions in body weight and improvements in glycemic control in selected patient populations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearch areas include:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eType 2 Diabetes:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Glycemic control and glucose-dependent insulin responses.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eObesity \u0026amp; Weight Management:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Body weight reduction and long-term metabolic outcomes.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAppetite Regulation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Hormonal pathways involved in hunger and satiety.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eMetabolic Homeostasis:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Interactions between energy intake, glucose regulation, and insulin sensitivity.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCardiometabolic Health:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Investigation of obesity-related metabolic complications.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eClinical outcomes depend on the population studied, treatment duration, and other individual factors.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eRegulatory Status \u0026amp; Safety\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eTirzepatide is an approved prescription medication, but research-grade tirzepatide preparations are not automatically approved medicines.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCommon adverse reactions associated with approved tirzepatide treatment include nausea, diarrhea, vomiting, constipation, and abdominal discomfort.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMore serious risks and precautions require medical assessment and are described in the official prescribing information.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe quality, purity, safety, and effectiveness of independently manufactured research preparations cannot be assumed equivalent to those of authorized pharmaceutical products.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eResearch Use Only\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eFOR SCIENTIFIC AND LABORATORY RESEARCH PURPOSES ONLY.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIntended exclusively for qualified professionals conducting legitimate scientific investigations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eResearch-grade preparations are not intended for human or veterinary administration, personal injection, self-medication, or unauthorized therapeutic use.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe designation “Research Use Only” does not constitute authorization to manufacture, market, distribute, or administer an unapproved medicinal preparation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePEPTITAN — PRECISION. SCIENCE. RESEARCH.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":59502059225352,"sku":null,"price":400.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1078\/2942\/8488\/files\/Frasco_de_Vidro_com_Arcos_Dourados.png?v=1794657660","url":"https:\/\/peptgrind.com\/products\/tirz3patid4-40mg","provider":"peptitan","version":"1.0","type":"link"}